<DOC>
	<DOC>NCT01398098</DOC>
	<brief_summary>Ultra-sound study to assess changes in intragastric volume after bowel preparation.</brief_summary>
	<brief_title>Measurement of Gastric Emptying During and After COLOKIT® Intake</brief_title>
	<detailed_description />
	<criteria>Subject who signed an informed consent to participate in the trial. Subject affiliated with Social Security Men and women aged 18 to 75 years. Subject with an indication of scheduled outpatient colonoscopy. colonoscopy performed within six hours after the second sequence COLOKIT®. Subject able to swallow tablets. 1. Women pregnant or likely to be (without contraception) or nursing. 2. Subject having any of the following diseases or conditions: allergy or hypersensitivity to the product tested or any of its excipients, nausea, vomiting or abdominal pain, clinically significant renal failure, primary hyperparathyroidism associated with hypercalcemia, congestive heart failure, ascites, a known or suspected bowel obstruction, megacolon (congenital or acquired) intestinal perforation, ileus, an inflammatory disease or suspected inflammatory bowel disease, swallowing disorders, known digestive motor disorders (gastroparesis, scleroderma, megaesophagus), diabetes mellitus (insulin or non insulindependent) a history of gastric surgery (partial or total) a contraindication to the anesthesia required for the completion of the colonoscopy, Any clinical condition which, in the opinion of the investigator, would not allow the subject to perform the test in good conditions.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>